A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

NCT03416335 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
36
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor's decision to terminate the development of the program due to changing landscape.

Conditions

Interventions

Sponsor

Sumitomo Pharma America, Inc.

Collaborators